Related Experiment Video
Updated: Oct 25, 2025

08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
11.1K
Nanoparticle mediated RNA delivery for wound healing
Elayaraja Kolanthai1, Yifei Fu1, Udit Kumar1
1Advanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, University of Central Florida, Orlando, Florida, USA.
Summary
This review explores using ribonucleic acid (RNA) therapies, including microRNA, short hairpin RNA, and silencing RNA, delivered via inorganic nanoparticles (NPs), to improve wound healing. These advanced RNA-based systems offer a promising solution for complex healing challenges.
Area of Science:
- Nanotechnology
- Molecular Biology
- Biomaterials Science
Background:
- Wound healing is a complex process affected by diseases like diabetes and aging.
- Current treatments have limited efficacy, creating an unmet need for improved wound closure rates and quality.
- Advances in nucleic acid research offer novel therapeutic avenues for wound healing.
Purpose of the Study:
- To review the application of various ribonucleic acid (RNA) molecules as therapeutic agents for wound healing.
- To explore the use of inorganic nanoparticles (NPs) as delivery systems for RNA-based therapeutics.
- To highlight the potential of RNA-NP conjugates in overcoming current wound healing limitations.
Main Methods:
- Literature review of research on RNA therapeutics (microRNA, shRNA, siRNA) for wound healing.
- Analysis of inorganic nanoparticle (NP) systems for targeted and controlled RNA delivery.
- Examination of studies investigating RNA-NP conjugates for enhanced wound repair efficacy.
Main Results:
- RNA molecules are key regulators in cellular processes relevant to wound healing.
- Inorganic NPs offer advantages for RNA delivery, including site-specific targeting, controlled release, and protection from degradation.
- RNA-NP systems show potential for improving wound closure rates and tissue regeneration.
Conclusions:
- RNA-based therapeutics, when delivered effectively using inorganic NPs, represent a promising strategy to address challenges in wound healing.
- Further research into optimizing RNA-NP delivery systems is crucial for clinical translation.
- This approach holds potential for developing advanced treatments for chronic and complex wounds.
More Related Videos
Related Concept Videos
Experimental RNAi
6.6K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.6K
RNA Interference
26.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.8K

